ThirdLaw Technologies LLC

Merion Station, PA · Biotech · Private

Cando, an open-source computational chemistry programming environment with LLVM-based compiler and machine learning capabilities for molecular design and evolutionary optimization of functional macrom

thirdlaw.tech →
Grants
$1.1M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Energy · Phase I · Development of Intelligent Systems for Atomically Precise Membranes, Macromolecular Catalysts and Therapeutics$150,000
Federal grantDepartment of Energy · Phase II · Development of Intelligent Systems for Macromolecular Catalysts, Atomically Precise Membranes and Therapeutics$1,000,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3123Silicon Insite, Inc.——
3124OncoSolutions LLC——
3125ASDDR, LLC——
3126ThirdLaw Technologies LLC——
3127AVANTYX, LLC——
3128MYRIEL, INC.——
3129MABSWITCH, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.